Abstract
Whole exome sequencing (WES) is increasingly used in research and clinical genetics as the cost of sequencing decreases and the interpretation improves. Genetic counselors need to be prepared to counsel a diverse patient population for this complex test. This commentary is a reflection of one genetic counselor’s experiences in counseling, consenting, and returning results for clinical and research WES for over 120 participants and patients. She reflects on how she overcame the initial challenges and concerns of counseling for WES and how her counseling evolved from a teaching based counseling model to an interactive patient-center counseling model. Her insights are offered to prepare other genetic counselors for the growing use of genomic testing.
Similar content being viewed by others
References
Amendola, L., Dautenbach, D., Scollon, S., Bernhardt, B., Biswas, S., East, K., et al. (2015). Illustrative Case Studies in the Return of Exome and Genome Sequencing Results. Personalized Medicine. Advance online publication. doi:10.2217/pme.14.89.
American College of Medical, G., & Genomics. (2013). Incidental findings in clinical genomics: a clarification. Genetics in Medicine, 15(8), 664–666.
Appelbaum, P. S., Fyer, A., Klitzman, R. L., Martinez, J., Parens, E., Zhang, Y., et al. (2014). Researchers’ views on informed consent for return of secondary results in genomic research. Genetic Medicine.
Austin, J., Semaka, A., & Hadjipavlou, G. (2014). Conceptualizing genetic counseling as psychotherapy in the era of genomic medicine. Journal of Genetic Counseling, 23(6), 903–909.
Berg, J. S., Khoury, M. J., & Evans, J. P. (2011). Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genetics in Medicine, 13(6), 499–504.
Berg, J. S., Adams, M., Nassar, N., Bizon, C., Lee, K., Schmitt, C. P., et al. (2013). An informatics approach to analyzing the incidentalome. Genetics in Medicine, 15(1), 36–44.
Bernhardt, B. A., Kellom, K., Barbarese, A., Faucett, W. A., & Wapner, R. J. (2014). An exploration of genetic counselors’ needs and experiences with prenatal chromosomal microarray testing. Journal of Genetic Counseling, 23(6), 938–947.
Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proceedings of the National Academy of Sciences of the United States of America, 106(45), 19096–19101.
Committee On, B., Committee On Genetics, A. N. D., American College Of Medical Genetics, A. N. D., Genomics, S., Ethical, & Legal Issues, C. (2013). Ethical and policy issues in genetic testing and screening of children. Pediatrics, 131(3), 620–622.
Dimmock, D. (2013). Whole genome sequencing: a considered approach to clinical implementation. Curr Protoc Hum Genet, Chapter 9, Unit9 22.
Farwell, K. D., Shahmirzadi, L., El-Khechen, D., Powis, Z., Chao, E. C., Davis, B. T., et al. (2014). Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genetic Medicine, 17(7), 578-86.
Glazov, E. A., Zankl, A., Donskoi, M., Kenna, T. J., Thomas, G. P., Clark, G. R., et al. (2011). Whole-exome re-sequencing in a family quartet identifies POP1 mutations as the cause of a novel skeletal dysplasia. PLoS Genetics, 7(3), e1002027.
Green, R. C., Berg, J. S., Berry, G. T., Biesecker, L. G., Dimmock, D. P., Evans, J. P., et al. (2012). Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genetics in Medicine, 14(4), 405–410.
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013a). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7), 565–574.
Green, R. C., Lupski, J. R., & Biesecker, L. G. (2013b). Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional. JAMA, 310(4), 365–366.
Henderson, G. E., Wolf, S. M., Kuczynski, K. J., Joffe, S., Sharp, R. R., Parsons, D. W., et al. (2014). The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations. The Journal of Law, Medicine & Ethics, 42(3), 344–355.
Iglesias, A., Anyane-Yeboa, K., Wynn, J., Wilson, A., Truitt Cho, M., Guzman, E., et al. (2014). The usefulness of whole-exome sequencing in routine clinical practice. Genetics in Medicine, 16(12), 922–931.
Kessler, S. (1997). Psychological aspects of genetic counseling IX. Teaching and counseling. Journal of Genetic Counseling, 6(3), 287.
Khan, C. M., Rini, C., Bernhardt, B. A., Roberts, J. S., Christensen, K. D., Evans, J. P., et al. (2015). How can psychological science inform research about genetic counseling for clinical genomic sequencing? Journal of Genetic Counseling, 24(2), 193–204.
Klee, E. W., Hoppman-Chaney, N. L., & Ferber, M. J. (2011). Expanding DNA diagnostic panel testing: is more better? Expert Review of Molecular Diagnostics, 11(7), 703–709.
Klitzman, R., Appelbaum, P. S., & Chung, W. (2013a). Return of secondary genomic findings vs patient autonomy: implications for medical care. JAMA, 310(4), 369–370.
Klitzman, R., Appelbaum, P. S., Fyer, A., Martinez, J., Buquez, B., Wynn, J., et al. (2013b). Researchers’ views on return of incidental genomic research results: qualitative and quantitative findings. Genetics in Medicine, 15(11), 888–895.
Majewski, J., Schwartzentruber, J., Lalonde, E., Montpetit, A., & Jabado, N. (2011). What can exome sequencing do for you? Journal of Medical Genetics, 48(9), 580–589.
McGuire, A. L., Joffe, S., Koenig, B. A., Biesecker, B. B., McCullough, L. B., Blumenthal-Barby, J. S., et al. (2013). Point-counterpoint. Ethics and genomic incidental findings. Science, 340(6136), 1047–1048.
Tabor, H. K., Stock, J., Brazg, T., McMillin, M. J., Dent, K. M., Yu, J. H., et al. (2012). Informed consent for whole genome sequencing: a qualitative analysis of participant expectations and perceptions of risks, benefits, and harms. American Journal of Medical Genetics Part A, 158A(6), 1310–1319.
Thompson, R., Drew, C. J., & Thomas, R. H. (2012). Next generation sequencing in the clinical domain: clinical advantages, practical, and ethical challenges. Advances in Protein Chemistry and Structural Biology, 89, 27–63.
Tomlinson, A., Skinner, D., Perry, D., Scollon, S., Roche, M., & Bernhardt, B. (2015). “Not Tied Up Neatly with a Bow”: Professionals’ Challenging Cases in Informed Consent for Genomic Sequencing. Journal of Genetic Counseling, 1–11. Advance online publication. doi:10.1007/s10897-015-9842-8.
Worthey, E. A., Mayer, A. N., Syverson, G. D., Helbling, D., Bonacci, B. B., Decker, B., et al. (2011). Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genetics in Medicine, 13(3), 255–262.
Wynn, J., Martinez, J., Duong, J., Zhang, Y., Phelan, J., Fyer, A., et al. (2015). Association of Researcher Characteristics with Views on Return of Incidental Findings from Genomic Research. Journal of Genetic Counseling. Advance online publication. doi:10.1007/s10897-014-9817-1.
Yang, Y., Muzny, D. M., Xia, F., Niu, Z., Person, R., Ding, Y., et al. (2014). Molecular findings among patients referred for clinical whole-exome sequencing. JAMA, 312(18), 1870–1879.
Acknowledgments
I am greatly appreciative of Barbara Bernhardt’s guidance and encouragement in the preparation of this manuscript, Dr. Wendy Chung’s mentorship and to Kevin Lynch for his careful edits.
I am appreciative of all the individuals who have participated in our study and my clinical patients.
The research presented in this work was funded by a grant from the National Human Genome Research Institute: R01 HG006600 (Dr. Chung).
Conflict of Interest
Julia Wynn declares that she has no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all subjects for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wynn, J. Genomic Testing: a Genetic Counselor’s Personal Reflection on Three Years of Consenting and Testing. J Genet Counsel 25, 691–697 (2016). https://doi.org/10.1007/s10897-015-9868-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-015-9868-y